100-75-4: N-Nitrosopiperidine

Also known as 1-nitrosopiperidine, it is a carcinogenic compound, the carcinogenicity of this compound demonstrated selective organotropism that resulted in 65–100% tracheal papillary tumors, dependent upon the applied dose level.

Additional information on CAS 100-75-4

Catalogue No.

VL3850096

CAS No.

100-75-4

Molecular Formula

C5H10N2O

Molecular Weight

114.15

Parent drug

N/A

IUPAC Name

1-Nitrosopiperidine

Synonyms

N/A

References

Fujioka, Takahiro, et al. “Effects of Membrane Fouling on N-Nitrosamine Rejection by Nanofiltration and Reverse Osmosis Membranes.” Journal of Membrane Science, vol. 427, Jan. 2013, pp. 311–19, https://doi.org/10.1016/j.memsci.2012.09.055 Haas, H., et al. “Comparative Studies with Different Doses of N-Nitrosomorpholine, N-Nitrosopiperidine, N-Nitrosomethylurea, and Dimethylnitrosamine in Syrian Golden Hamsters.” JNCI: Journal of the National Cancer Institute, vol. 51, no. 4, Oct. 1973, pp. 1295–3

Status

In-stock

Request a quote

100-75-4: N-Nitrosopiperidine

100-75-4: N-Nitrosopiperidine
Catalogue No.

VL3850096

CAS No.

100-75-4

Molecular Formula

C5H10N2O

Molecular Weight

114.15

Parent drug

N/A

IUPAC Name

1-Nitrosopiperidine

Synonyms

N/A

References

Fujioka, Takahiro, et al. “Effects of Membrane Fouling on N-Nitrosamine Rejection by Nanofiltration and Reverse Osmosis Membranes.” Journal of Membrane Science, vol. 427, Jan. 2013, pp. 311–19, https://doi.org/10.1016/j.memsci.2012.09.055 Haas, H., et al. “Comparative Studies with Different Doses of N-Nitrosomorpholine, N-Nitrosopiperidine, N-Nitrosomethylurea, and Dimethylnitrosamine in Syrian Golden Hamsters.” JNCI: Journal of the National Cancer Institute, vol. 51, no. 4, Oct. 1973, pp. 1295–3

Status

In-stock

ListName

N-Nitrosopiperidine

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url